NKO Partners has advised the Dr. Max Group on its acquisition of Serbian pharmacy chain Zlatni Lav. Bojovic Draskovic Popovic & Partners advised the seller.
BTS & Partners Advises on Eczacibasi Momentum’s Investment in RS Research
BTS & Partners has advised Eczacibasi Momentum on its USD 12 million Series A Round investment in RS Research.
Sorainen Provides Pro Bono Advice to Antegenes on Expansion
Sorainen has provided pro bono legal advice for Estonian health technology startup Antegenes on the possibilities of expanding to other countries.
TBK Announces Appointments and New Name: Tsvetkova Bebov & Partners
Tsvetkova Bebov Komarevski has changed its name to Tsvetkova Bebov & Partners, following the departure of Ilya Komarevski. Aside from the new name, the firm announced that Victoria Tzonkova and Damyan Leshev were elevated to Partner, while Eleonora Mateina was appointed to Head of Competition and Pharmaceuticals.
Cytowski & Partners Advises Surglogs on USD 10.5 Million Series A
Cytowski & Partners has advised Slovak healthcare startup Surglogs on its USD 10.5 million series A with Open Ocean. Royer Cooper Cohen Braunfeld reportedly advised Open Ocean on the deal.
Schoenherr and Binder Groesswang Advise on Sanofi's Acquisition of Origimm Biotechnology
Schoenherr has advised Sanofi on the acquisition of 100% of the shares in Origimm Biotechnology GmbH. Binder Groesswang and, reportedly, Squire Patton Boggs’ Frankfurt office advised the sellers on the deal.
ECJ’s Ruling in Favour of Boehringer - Pharmaceutical Companies May Retroactively Reduce Their VAT Liabilities
The Hungarian State unlawfully collected a sizeable amount of VAT from pharmaceutical companies ruled the European Court of Justice (ECJ) in a recent preliminary ruling procedure, initiated by Boehringer Ingelheim against the Hungarian tax authority.